Since disruption of amino acid and lipid metabolism appears central to MacTel aetiology, in this study we closely examined the transmembrane SLC family proteins which transport these molecules between sites of synthesis and utilisation, and which represent attractive drug targets29. The gene discussed is CCL21; the disease is macular telangiectasia type 2.